Teladoc Health (NYSE:TDOC) Stock Rating Lowered by ValuEngine

Share on StockTwits

Teladoc Health (NYSE:TDOC) was downgraded by analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a research report issued on Thursday, ValuEngine reports.

A number of other research firms also recently weighed in on TDOC. Bank of America started coverage on Teladoc Health in a report on Thursday, June 13th. They set a “buy” rating and a $65.00 target price for the company. Deutsche Bank assumed coverage on Teladoc Health in a research note on Thursday, September 12th. They issued a “buy” rating and a $76.00 price target for the company. Piper Jaffray Companies set a $87.00 price target on Teladoc Health and gave the company a “buy” rating in a research note on Friday, August 16th. Jefferies Financial Group reissued a “buy” rating and set a $95.00 target price on shares of Teladoc Health in a research note on Tuesday, July 2nd. Finally, SunTrust Banks boosted their target price on Teladoc Health to $80.00 and gave the stock a “positive” rating in a research note on Tuesday, August 6th. Two equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $79.14.

TDOC stock opened at $67.45 on Thursday. The company has a quick ratio of 7.56, a current ratio of 7.56 and a debt-to-equity ratio of 0.43. The company has a fifty day moving average price of $64.47 and a two-hundred day moving average price of $62.07. Teladoc Health has a one year low of $42.08 and a one year high of $75.93.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.41) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.40) by ($0.01). Teladoc Health had a negative return on equity of 10.64% and a negative net margin of 21.85%. The company had revenue of $130.30 million for the quarter, compared to the consensus estimate of $129.54 million. During the same period last year, the firm earned ($0.40) earnings per share. The company’s revenue for the quarter was up 37.8% compared to the same quarter last year. Research analysts forecast that Teladoc Health will post -1.56 EPS for the current year.

In related news, insider Lewis Levy sold 1,350 shares of Teladoc Health stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $67.79, for a total transaction of $91,516.50. Following the sale, the insider now directly owns 5,230 shares in the company, valued at $354,541.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, President Peter A. Mcclennen sold 13,753 shares of Teladoc Health stock in a transaction that occurred on Monday, July 15th. The shares were sold at an average price of $70.99, for a total value of $976,325.47. Following the sale, the president now owns 29,412 shares in the company, valued at $2,087,957.88. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 67,036 shares of company stock worth $4,622,050. 3.95% of the stock is owned by corporate insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Jennison Associates LLC raised its stake in Teladoc Health by 60.6% during the second quarter. Jennison Associates LLC now owns 1,172,135 shares of the health services provider’s stock valued at $77,841,000 after buying an additional 442,140 shares during the last quarter. Aperio Group LLC raised its stake in Teladoc Health by 28.3% during the second quarter. Aperio Group LLC now owns 7,170 shares of the health services provider’s stock valued at $476,000 after buying an additional 1,582 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in Teladoc Health by 5.9% during the second quarter. Charles Schwab Investment Management Inc. now owns 583,858 shares of the health services provider’s stock valued at $38,775,000 after buying an additional 32,535 shares during the last quarter. C WorldWide Group Holding A S raised its stake in Teladoc Health by 124.0% during the second quarter. C WorldWide Group Holding A S now owns 234,834 shares of the health services provider’s stock valued at $15,595,000 after buying an additional 130,000 shares during the last quarter. Finally, UBS Asset Management Americas Inc. raised its stake in Teladoc Health by 16.6% during the second quarter. UBS Asset Management Americas Inc. now owns 297,466 shares of the health services provider’s stock valued at $19,755,000 after buying an additional 42,387 shares during the last quarter.

About Teladoc Health

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Read More: Short Selling Stocks and Day Traders

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Blue Chip Wealth Management Inc. Sells 400 Shares of Facebook, Inc.
Blue Chip Wealth Management Inc. Sells 400 Shares of Facebook, Inc.
NVIDIA Co.  Shares Purchased by Covenant Asset Management LLC
NVIDIA Co. Shares Purchased by Covenant Asset Management LLC
Covenant Asset Management LLC Reduces Position in iShares S&P Small-Cap 600 Value ETF
Covenant Asset Management LLC Reduces Position in iShares S&P Small-Cap 600 Value ETF
Covenant Asset Management LLC Has $1.21 Million Position in Incyte Co.
Covenant Asset Management LLC Has $1.21 Million Position in Incyte Co.
Covenant Asset Management LLC Boosts Stake in IDEXX Laboratories, Inc.
Covenant Asset Management LLC Boosts Stake in IDEXX Laboratories, Inc.
CHINA GAS HOLDI/ADR  Shares Up 0.8%
CHINA GAS HOLDI/ADR Shares Up 0.8%


 
© 2006-2019 Zolmax.